Global Sepsis Treatment Market, By Stages (Sepsis, Severe Sepsis, Septic Shock), Pathogen Type (Bacteria, Fungi, Virus), Mechanism of Action (Antibiotics, Corticosteroids, Vasoactive Agents, Analgesics and Others), Treatment (Drugs, Surgery), Route of Administration (Oral, Intravenous and Others), End-User (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Sepsis Treatment Market
The sepsis treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 7.0% in the above-mentioned research forecast period. Initiatives taken by the market players can drive the sepsis treatment market growth.
For instance,
- In April 2019, Beckman Coulter, Inc. received the U.S. FDA 510(k) clearance for sepsis indicator. Sepsis indicator is first-of-its-kind and based on hematology cellular biomarker, it is designed to help physicians to identify patients with sepsis in an emergency condition or who are at increased risk of developing sepsis
Sepsis is one of the oldest illness which is derived from the Greek word “make rotten” and is characterized by the release of chemical directly in the blood and the chemical is released by the body’s own immune system. The chemical which is released is used to fight against the infections but when the chemical releases in excess amount, it leads to inflammation throughout the body that can lead to multiple organ damage. A person with sepsis experiences altered mental status, high respiratory rate and low blood pressure. Different symptoms for sepsis are fever (above 101ºF and below 96.8ºF), higher breathing rate (20 breaths per minute) and increase in heart rate that is 90 beats per minute. It should be treated early otherwise severe sepsis can cause organ damage.
Increase in prevalence of sepsis can act as a driver for the sepsis treatment market growth. For instance, around 1.7 million adult population from America suffer from sepsis and it is also estimated that 270,000 Americans die due to sepsis that is 1 to 3 people die from sepsis. According to WHO, there were approximately 48.9 million cases and 11 million sepsis-related deaths occur worldwide in 2017. As the older people are more at the risk of getting sepsis due to weak immune system, therefore increase in aging population can also drive the sepsis treatment market growth. In addition, increasing demand for antibiotic resistant bacterial strains, growing incidences of hospital acquired infections and high prevalence of numerous chronic diseases such as diabetes can also increase the sepsis treatment market growth. However, low healthcare expenditure in low and middle income countries, lack of awareness among the population and introduction of generic sector has decreased the sepsis treatment market growth.
This sepsis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the sepsis treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Sepsis Treatment Market Scope and Market Size
The sepsis treatment market is segmented on the basis of stages, pathogen type, mechanism of action, treatment, route of administration, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of stages, the sepsis treatment market is segmented into sepsis, severe sepsis and septic shock.
- On the basis of pathogen type, the sepsis treatment market is segmented into bacteria, fungi and virus.
- On the basis of mechanism of action, the sepsis treatment market is segmented into antibiotics, corticosteroids, vasoactive agents, analgesics and others.
- On the basis of treatment, the sepsis treatment market is segmented into drugs and surgery. Drugs are further segmented to vasoconstrictor, antibiotics, anti-hypertensive drugs and others. Vasoconstrictor is further segmented to dopamine and norepinephrine. Antibiotics are further segmented to ceftriaxone, meropenem, ceftazidime, cefotaxime, cefepime, piperacillin and tazobactam, ampicillin and sulbactam, imipenem/cilastatin, levofloxacin and clindamycin. Anti-hypertensive drugs are further segmented to norepinephrine and phenylephrine. Others are further segmented to steroids and intravenous fluids.
- On the basis of route of administration, the sepsis treatment market is segmented into oral, intravenous and others.
- On the basis of end-user, the sepsis treatment market is segmented to hospitals, homecare, specialty clinics and others.
- On the basis of distribution channel, the sepsis treatment market is segmented into direct, online pharmacy, retailers and others.
Global Sepsis Treatment Market Country Level Analysis
Global sepsis treatment market is analysed and market size information is provided by the country, stages, pathogen type, mechanism of action, treatment, route of administration, end-user and distribution channel as referenced above.
The countries covered in the sepsis treatment or market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to increasing healthcare expenditure and favourable diagnostic facilities for the sepsis diagnosis. Asia-Pacific holds the second largest market share due to the growing number of surgical procedures along with prevalence of improved healthcare infrastructure and increasing number of research studies and activities.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The sepsis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to sepsis treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the sepsis treatment market in the growth period.
Competitive Landscape and Sepsis Treatment Market Share Analysis
The sepsis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sepsis treatment market.
The major players covered in the sepsis treatment market report are Abbott, Pfizer Inc, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Adrenomed AG, AM-Pharma B.V., Amomed Pharma GmbH, Asahi Kasei Corporation, Endacea, Inc, InflaRx N.V., La Jolla Pharmaceutical Company, Formosa Laboratories, Inc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd, Dascena, Inc, AstraZeneca, Merck & Co., Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-